|




The Natural Prostate Cure















Download This Book
(right-click and choose "save target/link as")


|
Chapter 5: Science and Beta-sitosterol
______________________________________________________
Science has shown that the most
powerful, proven and effective nutritional supplement for prostate health is a
common plant alcohol called beta-sitosterol. Beta-sitosterol is found in
literally all of the vegetables you eat, and is the most prominent plant sterol
in nature. Actually, “beta-sitosterol” is really a combination of several
additional sterols, including campesterol, stigmasterol, and brassicasterol.
Americans are generally estimated to eat about 300 mg a day of natural beta-sitosterol,
and vegetarians to eat about twice that much.
Traditionally, such herbs as saw
palmetto, Pygeum species, nettles, star grass, and other herbs have been used to
treat prostate problems. The trouble with using these is that generally they
contain about a mere one-part-in-three-thousand of the beta-sitosterol complex.
A typical analysis of saw palmetto shows that it contains a variety of fatty
acids (capric, lauric, myristic, palmitic, palmitoleic, stearic, oleic, linoleic,
linolenic, arachic, and eicosenoic), and minute traces of sterols and other
plant chemicals that are biologically insignificant. Obviously, these herbal
formulas just do not contain any effective amounts of active ingredients. That
means you would have to eat about a pound of saw palmetto berries to get a basic
dose of 330 mg of beta-sitosterol. Even with the most expensive “10x” (ten
times) extracts of these herbs, one would still have to eat about two-hundred
500 mg capsules to get the 330 mg of beta-sitosterol! So, it is obvious that
these herbs are ineffective, despite their continual
promotion by the so-called natural health industry. Please understand
that saw palmetto, Pygeum africanum, and other herbs and their extracts are
simply biologically irrelevant, because they do not contain enough active
ingredient. Even when the label says “85 percent fatty acids and sterols,” you
can be sure that it really means “nearly all fatty acids and almost no sterols.”
The saw palmetto products sold in America simply have no value, no matter how
much advertising you have read. You won’t see any saw palmetto or other herbal
prostate product with any significant amount of beta-sitosterol in it.
What about the herbal extracts sold by
prescription in Europe? Those extracts are standardized according to beta-sitosterol
content, regardless of its source, by law, and this is prominently and clearly
stated on the label. Whether you buy Permixon in France; Harzol, Tadenan, or
Azuprostat in Germany; or Prostaserene in Belgium, they are all based on how
much actual beta-sitosterol content they have. They are weak and very
expensive—for example, a bottle of 60 tablets of Permixon, containing 30 mg of
beta-sitosterol per tablet, will cost about $50 in U.S. dollars. You would have
to take ten a day to get any benefit which would then cost you about $250 a
month.
After one thoroughly researches beta-sitosterol,
it becomes obvious that such herbs are a completely uneconomical source, while
soybeans, sugarcane pulp, and pine oil (tall oil) are all excellent, natural,
inexpensive sources. Many cane-sugar processors now extract the valuable
chemicals from the pulp, after the sugar is pressed out. Only a few companies
sell actual beta-sitosterol supplements. The most popular brand contains a
useless amount of 20 mg and sells for $29.95 for 60 tablets! Find one with 300
mg.
There are dozens of classic double
blind studies done with men regarding the effects of beta-sitosterol on BPH
(benign prostate hypertrophy) or enlarged prostate. We’ll discuss a few of these
to give you some examples of the first-rate research that has been done around
the world at leading hospitals and clinics.
At the Institute of Clinical Medicine
at the University of Rome,1
DiSilverio and his colleagues studied thirty-five men with BPH for three months,
and gave half of them a placebo (inert capsules). They concluded, “On the basis
of these considerations, monotherapy with a special S. repens extract [a special
high potency beta-sitosterol extract] may be more favorably accepted, on account
of similar clinical results, when compared to the combination therapy
cyproterone acetate plus tamoxifen.”
At the Hospital Ambroise in Paris,2
Champault and two other doctors did a classic double-blind study on
one-hundred ten men, half of them receiving a placebo. They concluded: “Thus, as
predicted by pharmacological and biochemical studies, PA109 [4 tablets of
Permixon daily] would appear to be a useful therapeutic tool in the treatment of
BPH.” They should have used more than that.
At the Klinische Endokrinologie in
Freiburg, Germany,3 Zahradnik
and other doctors demonstrated that beta-sitosterol taken from star grass (and
sold as the prescription extract Harzol) lowered prostaglandin levels. In regard
to the development of prostate enlargement, it was shown that high prostaglandin
levels supported tumor growth.
Doctors at the University of Padova,
Italy4 studied the effect of a special high potency beta-sitosterol
extract (from Pygeum africanum) on twenty-seven men with BPH. Dr. Tasca and his
associates measured urine flow and other parameters in men ranging from ages 49
to 81, compared to men receiving a placebo. The men receiving beta-sitosterol
achieved much-improved urine flow. This extract is not available to
non-scientists.
At the Institute of Medical Sciences
in Madras, India,5 Doctors
Malini and Vanithakumari have studied the effect of beta-sitosterol on the
prostates of rats. In only six weeks, improved metabolism and reduced weights of
their prostates was seen. This was a unique and thorough study.
At the University of Dresden, Germany,6
Doctors Klippel, Hilti, and Schipp studied one-hundred and seventy-seven
BPH men for six months. Half the men received a placebo and half received the
prescription extract Azuprostat containing 130 mg of beta-sitosterol. To
substantiate their research, thirty-two references were cited. They carefully
screened all the men, who were tested extensively during the study. They
concluded, “These results show that beta-sitosterol is an effective option in
the treatment of BPH.”
A nine-week double blind study of
fifty men was conducted at the University of Basel, Switzerland.7
Dr. Vontobel and his colleagues studied a special extract of nettles
containing a high concentration of beta-sitosterol They said, “The use of beta-sitosterol
from nettles, in the evaluation of the objective parameters showed significant
differences; the men who received the supplement improved significantly.” By the
way, you cannot buy this in a store.
At the University of Bochum in Herne,
Germany,8 Dr. Berges and his
associates used pure beta-sitosterol with two-hundred men, over the course of a
year, half of whom received a placebo. They said, “Significant improvement in
symptoms and urinary flow parameters show the effectiveness of beta-sitosterol
in the treatment of BPH.” This is clearly one of the most important and
well-done studies on prostate ever published.
Doctor Bassi and others at the
University of Padova, Italy9
for two months, studied forty men who had BPH and were given an extract of
Pygeum africanum containing a high beta-sitosterol content. Half the men
received a placebo. They concluded, “The preliminary results demonstrate a
significant improvement of the frequency, urgency, dysuria [difficult, painful
urination], and urinary flow in patients treated with the active drug.”
At eight different urological clinics
in Europe10 a collective study
over a two-month period was done of 263 total patients with BPH. They were given
either Tadenan (a Pygeum africanum extract standardized for beta-sitosterol
content) or a placebo. This very extensive study was coordinated among different
clinics and different doctors who all agreed, “treatment with the Pygeum
africanum extract led to a marked clinical improvement. A comparison of the
quantitative parameters showed a significant difference between the Pygeum
africanum group and the placebo group, with respect to therapeutic response.”
The Pygeum extracts you buy in the store are much weaker than this.
A study was done on twenty-three
patients at the Urological Clinik of Krankenhauser, in Germany.11
Dr. Szutrely gave the patients with prostate enlargement either Harzol
(herbal extract standardized for beta-sitosterol content) or a placebo, over a
two-month period. He measured their prostates with ultrasound equipment before
and after treatment. At the end he said, “within the scope of a controlled
double blind study to demonstrate the effect of conservative therapy of benign
prostatic hyperplasia with Harzol, ultrasonic examination of the prostate
adenoma [enlargement] was carried out on twenty-three patients before and after
therapy, with the trial preparation of a placebo. Within a two-month treatment
with Harzol there was a significant change in echo structure of the prostate
adenoma. This is interpreted as a reduction in the interstitial formation of
oedema [swelling].”
A unique review12
of studies, over a thirty-one-year period, used eighteen different
international trials involving 2,939 men with BPH. They were treated with strong
extracts of saw palmetto, standardized for beta-sitosterol content. After
reviewing all these studies, the researchers announced, “The evidence suggests
that Serenoa repens [saw palmetto] extract improves urologic symptoms and flow
measures.”
Another unique review, in a different
manner, was done at the Department of Urology in Glasgow, Scotland.13
Dr. Buck did a twelve-page review of herbal therapy for the prostate,
including Harzol, Tadenan, Permixon, Strogen, and Sabalux (all European
prescription herbal extracts standardized for beta-sitosterol content). He
documents his review with fifty-nine published, worldwide studies, and discusses
the biological basis of prostate illness. His conclusions of the efficacy of
herbal treatment of prescription drugs and therapy are well founded.
Dr. Braeckman performed a study done
at the University of Brussels, Belgium14
using Prostaserene (an extract standardized for beta-sitosterol) for six
weeks. This led him to conclude, “Traditional parameters for quantifying
prostatism, such as the International Prostate Symptom Score, the
quality-of-life score, urinary flow rates, residual urinary volume, and prostate
size were found to be significantly improved after only 45 days of treatment.
After ninety days of treatment, a majority of patients (88%) and treating
physicians (88 percent) considered the therapy effective.”
At the Veterans Administration in
Minneapolis15 doctors did a
very thorough review of the research on beta-sitosterol, going back over thirty
years and including thirty-two references. They concluded that beta-sitosterol
had “the greatest efficacy amongst phytotherapeutical substances.” They also
concluded that, “Beta-sitosterol improves urological symptoms and flow
measures.” A review like this is very impressive, as it uses many studies
condensed into one comprehensive presentation.
At the University of Rome16
doctors gave men with BPH (average age of sixty-eight) Permixon for ninety
days. This caused a drop of 50 percent in prostate gland DHT levels, and a rise
of 72 percent in testosterone levels. More proof that testosterone is necessary
for healthy prostate metabolism. It is not the serum level of DHT that is
critical, but how much DHT binds to the prostate itself.
At St. Luke’s Hospital in NYC17
doctors did an extensive review of herbal supplements for prostate
conditions and noted that all of them had beta-sitosterol as the active
ingredient, just like the prescription herbal products sold in Europe. They
concluded that beta-sitosterol is the most promising of all medical therapies.
Dr. Berges and his associates at Ruhr
University in Germany18
published another study on beta-sitosterol, in 2000. This time they wanted to do
a very long-term study, over an eighteen-month period, to prove beyond any doubt
the lasting effects of beta-sitosterol therapy on prostate enlargement. This
was, of course, a classic double blind study, and they measured many basic
indexes to show in detail how the men fared. The untreated men got worse with
time, while the men given beta-sitosterol improved in all measured ways. They
concluded, “The beneficial effects of beta-sitosterol treatment… were maintained
for eighteen months.” This leaves no doubt as to the long-term effectiveness.
These are only a few of the many
dozens of studies that have appeared in the major medical journals. They show,
in fact, that betasitosterol is the active ingredient in herbs. American herbal
products, even the most expensive extracts that claim “85 percent fatty acids
and sterols,” have almost no beta-sitosterol in them. Analytical studies prove
there are no significant active ingredients in any of these products. This is
never mentioned on the label, suggesting that almost every over-the-counter
natural prostate remedy sold in the U.S. simply has no value.
References:
1. European
Urology, v.21 (1992), pp. 309-14
2. British Journal of Clinical Pharmacology, v.18 (1984), pp. 461-62
3.
Klinische Endokrinologie, v.98 (1980), pp. 102-08
4. Minerva
Urologica e Nefrologica, v.37 (1985), pp. 87-91
5. Medical
Science Research, v.16 (1983), pp. 1067-68
6. British
Journal of Urology, v.80 (1997), pp. 427-32
7. Urolage
A, v.24 (1985), pp. 49-51
8. Lancet,
v.345 (1995), pp. 1529-32
9. Minerva
Urologica e Nefrologica, v.39 (1987), pp. 45-50
10. Prostate,
v.37 (1998), pp. 187-93
11. Wiener
Klinische Wochenschrift, v.22 (1990), pp. 667-73
12.
Medizinische Klinik, v.77 (1982), pp. 520-22
13. Journal of
the Am. Med. Assn., v.280 (1998), pp. 1604-09
14. British
Journal of Urology, v.78 (1996), pp. 325-36
15. Current
Therapeutic Research, v.55 (1994), pp. 776-85
16. British
Journal of Urology, v.83 (1999), pp. 976-83
17. British
Journal of Urology, v.85 (2000), pp. 842-46
18. Prostate,
v.37 (1998), pp. 77-83
|